important considerations in the management of hr , her2-negative early breast cancer
Published 1 year ago • 6.2K plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
4:45
advances and considerations in the treatment and management of hr , her2-, advanced breast cancer
-
30:49
conceptualizing guidelines to manage patients with hr–positive, her2-negative early breast cancer
-
34:58
management of hr-positive/her2-negative early breast cancer: taking direction from the updated gu...
-
34:12
new and emerging agents in her2-negative metastatic breast cancer: implications for practice
-
11:07
adjuvant therapy for early stage er-positive, her2-negative invasive breast cancer
-
0:35
key challenge associated with the management of hr /her2- breast cancer
-
54:38
what is the relationship between estrogen and breast cancer? | dr. avrum bluming
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
11:12
her2-low breast cancer: destiny or good science?
-
1:36
an overview of the meribel study in her2-negative breast cancer
-
1:57
impact of cdk4/6 inhibitors on hr-positive, her2-negative advanced breast cancer
-
6:39
expert report on advances in the management of her2-negative and her2-low advanced breast cancer
-
46:25
the role of biomarkers in hr-positive/her2-negative early breast cancer: from clinical analysis t...
-
7:15
asco 2023 expert report in hr positive, her2 negative breast cancer by catherine harper-wynne
-
15:00
new fda-approved targeted drug for treatment-resistant, er positive her2 negative breast cancer
-
31:07
recent advances in the treatment of hr positive, her2 negative metastatic breast cancer
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
1:25
current state of cdk4/6 inhibitors in metastatic her2-negative breast cancer
-
58:22
adjuvant cdk4 and 6 inhibition to prevent recurrences in high-risk hr /her2- early breast cancer
-
2:01:47
her2-negative breast cancer | beyond the guidelines: clinical investigator perspectives on the ma...
-
6:09
ki-67 index after neoadjuvant et as a prognostic biomarker for hr /her2- early breast cancer
-
4:12
optimizing treatment in patients with early-stage her2-positive breast cancer